AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

Market Cap	12.84B +8.4%
Revenue (ttm)	33.01B +4.5%
Net Income	1.51B +8.3%
EPS	107.03 +8.1%
Shares Out	14.41M
PE Ratio	8.32
Forward PE	n/a
Dividend	36.00 (4.09%)
Ex-Dividend Date	Feb 26, 2026

Volume	19,400
Average Volume	42,615
Open	889.00
Previous Close	880.00
Day's Range	886.00 - 894.00
52-Week Range	765.00 - 918.00
Beta	0.51
RSI	45.02
Earnings Date	Apr 14, 2026

About AFC-HD AMS Life Science

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs,...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1969
• Employees: 1,008
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2927

Financial Performance

In fiscal year 2025, AFC-HD AMS Life Science's revenue was 32.66 billion, an increase of 8.18% compared to the previous year's 30.19 billion. Earnings were 1.45 billion, an increase of 15.65%.